Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$7.49 USD
-0.01 (-0.13%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.48 -0.01 (-0.13%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-1.20 | 0.00% |
Earnings Summary
For their last quarter, Adverum Biotechnologies (ADVM) reported earnings of -$0.89 per share, beating the Zacks Consensus Estimate of $-1.27 per share. This reflects a positive earnings surprise of 29.92%. Look out for ADVM's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$1.20 per share, reflecting a year-over-year increase of 63.64%.
Earnings History
Price & Consensus
Zacks News for ADVM
Ginkgo (DNA) to Report Q2 Earnings: What's in the Cards?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services